Team:ETH Zurich/Wetlab/Chemostat Selection

Chemostat selection

Goal

The goal of our project is to find the minimal genome that is able to create a living E. coli in a specific environmental condition. In the previous section, we have introduced the method we want to apply for reducing the genome. However, manually selecting for those bacteria that have successfully reduced their genomes is obviously impossible. Therefore, we have to find a mechanism that automatically selects cells possessing a reduced genome.

Idea

Our idea is to set up a continuous bacterial culture in which cells with a reduced genome overgrow those maintaining more chromosomal DNA.

However, bacteria with a smaller genome do not automatically grow faster than those containing more DNA. This is due to the fact that the rate of proliferation is not only influenced by the replication velocity, but also by other factors such as protein synthesis, etc. Therefore, we have to introduce a constraint that renders DNA synthesis the limiting factor of the growth rate. In this scenario, reducing chromosomal DNA would speed up replication leading to fastest growth of those cells with the smallest genome. This way, we would not have to look for bacteria with reduced genomes, but we could let them do it for us!

Method

Chemostat

A chemostat is the instrument of choice for setting up a continuous culture. It is characterized by a continuous influx of medium, and an efflux of bacterial culture of the same volume. Since the volume of the continuous culture is kept constant, the growth rate of the population can be set by the dilution rate. Under these conditions, slowly growing (growth rate < dilution rate) cells will be washed out of the culture, while the fastest growing clone will take the lead and finally dominate the entire culture.

A model of the selection mechanism can be found in Chemostat Selection, where we estimate the initial parameters for optimal selection.

Growth constraint

As mentioned above, we want to introduce a constraint that renders DNA synthesis the limiting factor of the growth rate. DNA synthesis in bacterial cells is accomplished using the following biosynthetic pathway:

The thymidylate synthase catalyzes the methylation of dUMP to yield dTMP. Phosphorylation then converts dTMP into dTTP, one of the four building blocks of DNA. In contrast to the other three nucleotides DNA is made of, dTTP is exclusively used for DNA, but not for RNA synthesis. Therefore, impairing the activity of the thymidylate synthase should interfere quite specifically with DNA synthesis.

Our idea is to knockout the thymidylate synthase of the E. coli strain we use for genome reduction and then add thymidine to the continuous culture in a concentration that renders DNA synthesis the limiting factor for the growth rate.

The underlying assumption is that a thymidylate synthase knockout can no longer synthesize DNA from glucose and thus depends entirely on the availability of thymidine in the medium. Therefore, if the thymidine concentration is kept low, DNA replication should be slowed down. A decreased replication rate then results in a slower growth rate. This way, by fixing the thymidine supply rate, we can influence the growth rate of the knockout mutant.

Supporting our assumptions, Escartin et al. showed that an E. coli strain expressing an enzymatically less active thymidylate synthase shows a significantly lower incorporation rate of radioactively labeled thymidine into DNA indicating a reduced replication velocity (1). The same strain grows poorly in thymidine-deprived growth media. Other reports support that a decreased replication rate results in a slower growth rate and decreased replicative fitness (2).

Lab results

Growth experiments with E. coli strains of different genomic sizes

To test our hypothesis of selecting for strains with smaller genome size in a chemostat setup, we have chosen, to compare growth behaviour (growth rate and thymidine yield) of strains with different genome size. For this purpose we used MG1655 and MDS42, two strains with the same background, with different genome size. MDS2 has a 14.3% smaller genome size than MG1655. We ordered both at [http://www.scarabgenomics.com/ ScarabGenomics ].

For a first characterization of the growth behavior of these two strains, we performed growth experiments in LB medium.

Figure 2: MG1655 and MDS42 were cultivated in 500ml baffled flasks with 100ml LB medium at 37°C and 220 rpm

We observed a higher growth rate for MG1655 than for MDS42.

Labeling of E. coli strains of different genomic sizes

Since growth of 2 strains in the same enviroment is not observable by measurement of the optical density, we decided to label them by expression of 2 different fluorescent proteins. We have constructed a RFP generator and a GFP generator on low-copy plasmids (pCK01) and transduced them into MG1655 and MDS42. An important issue when labeling strains with different genome size to compare their genome size specific behaviour is to use plasmids with the same copy-number to keep the relative difference of needed amount of nucleotides the same. We have chosen to use a low-copy plasmid to keep the added protein burden low. To ensure that the fluorescent signal is proportional to cell concentration, we compared measurements of the optical density with fluorescence signal.

evt graph showing this

evt calibration curves for RFP signal and GFP signal

Thymidylate synthase knockout using phage transduction

The knockout of thyA in MG1655 and MDS42 were performed by P1 vir transduction (referemce for method). For this we used a thyA mutant from the keio collection (link to keio collection) as the donor cells to transfer its kanamicin-resistence gene into MG1655 and MDS42. The mutants from the keio collection are single knockouts which have each one single gene replaced by a kanamicin-resistence gene. Different verification methods were performed to verify successful knockout of thyA in MG1655 and MDS42. First we selected the transduced strains on kanamicin-plates, second we performed an XGal-test to distinguish colonies of the donor cells (keio thyA mutant) from the colonies of the receptor cells (MG1655 and MDS42) and third by growth on minimal glucose medium with and without supplemented thymidine (40ug/ml). Since BW25113, the strain of the keio collection, is lac- (∆lacZ4787(::rrnB-3)) and MG1655 and MDS42 lac+, XGal-screen is a fast method to distinguish residual donor cells in the phage lysate from the receptor cells. For further verification we will perform a colony PCR of the mutants.

Growth experiments with thymidylate synthase knockout strains

We performed growth experiments with the knockout mutants in LB and minimal glucose medium with different thymidine concentrations.

graph

What does this graph show ?

Keio thymidylate synthase knockout strains

BW25113: ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), lambda-, rph-1, ∆(rhaD-rhaB)568, hsdR514

JW2795 7 90 11 D B2827 thyA

Phage transduction knockout strains

MG16555 thyA: F-, lambda-, rph-1, thyA- MDS42 thyA: F-, lambda-, rph-1, thyA-

References

(1) Escartin F., Skouloubris S., Liebl U., Myllykallio H. (2008): Flavin-dependent thymidylate synthase X limits chromosomal DNA replication. Proc Natl Acad Sci 22 105(29):9948-52.

(2) Helmstetter C. (1996): Timing of synthetic activities in the cell cycle. Escherichia coli and Salmonella: Cellular and Molecular Biology. eds Neidhardt FC et al. (Am Soc Microbiol, Washington D. C.): 1627–1639.

() reference with P1 transduction method

(x) : Pósfai G, Plunkett G 3rd, Fehér T, Frisch D, Keil GM, Umenhoffer K, Kolisnychenko V, Stahl B, Sharma SS, de Arruda M, Burland V, Harcum SW, Blattner FR. Emergent Properties of Reduced-Genome Escherichia coli. Science. 2006 May 19;312(5776):1044-6. Epub 2006 Apr 27.